The objective of this study was to longitudinally evaluate the neurodevelopmental (ND) outcome in congenital diaphragmatic hernia (CDH) survivors during the first 3 years of life. STUDY DESIGN: The study cohort consists of 47 CDH survivors that were enrolled in our prospective, follow-up program between July 2004 and September 2010, and underwent serial ND evaluations during the first 3 years of life. ND outcomes were evaluated using the Bayley Scales of Infant Development (BSID)-II or BSID-III. Persistent ND impairment was defined as a score that remained p79 for the cognitive, language and psychomotor domains at the most recent follow-up visit compared with the first assessment. RESULT: The median age at first and last evaluation was 8 (range, 5 to 15) and 29 (range, 23 to 36) months, respectively. During the follow-up, ND scores improved to average in 17%, remained average in 60%, remained delayed in 10%, improved from severely delayed to mildly delayed in 2% and deteriorated from average to delayed in 15%. Motor scores improved to average in 26%, remained average in 55%, remained delayed in 8% and improved from severely delayed to mildly delayed in 11%. Intrathoracic liver position (P ¼ 0.004), preterm delivery (P ¼ 0.03), supplemental O 2 requirement at day of life 30 (P ¼ 0.007), age at discharge (P ¼ 0.03), periventricular leukomalacia (PVL; P ¼ 0.004) and initial neuromuscular hypotonicity (P ¼ 0.01) were associated with persistent motor delays. No relationship was found between patient's characteristics and the risk of persistent cognitive and language delays. CONCLUSION: (1) The majority of children with CDH are functioning in the average range by early preschool age, (2) most children who had early delays showed improvement in their ND outcome, (3) children showing delays in all the three domains were the least likely to show improvement and (4) CDH severity appears to be predictive of persistent psychomotor delays.
INTRODUCTION
Congenital diaphragmatic hernia (CDH) is a developmental defect of the diaphragm that occurs in B1 to 2500 live births. CDH presents with a broad spectrum of severity dependent upon components of pulmonary hypoplasia and pulmonary hypertension. 1 Over the past two decades, advances in surgical technique and intensive care for infants with CDH have led to decline in mortality. As survival has improved, longer-term disability, particularly neurological outcome, is a key outcome measure for these children. [2] [3] [4] [5] [6] [7] [8] Neurodevelopmental (ND) dysfunction has been recognized as the most common and potentially most disabling outcome of CDH and its treatment. 2 Early reports revealed a concerning incidence of significant impairments in widespread ND domains: fine and gross motor skills, visuospatial skills and cognition, attention and behavioral skills, and speech and language skills. [4] [5] [6] 9, 10 Alone or in combination, these findings may significantly decrease the quality of life for children with CDH and their families, as well as result in significant costs to society.
The prevalence of early adverse ND outcomes appears to vary according to the severity of CDH. We, as well as others, previously demonstrated that intrathoracic liver position, need for extracorporeal membrane oxygenation (ECMO), patch requirement, supplemental oxygen requirement beyond 30 days of life (DOL) and neuromuscular hypotonicity are strong predictors of impaired neurological function in CDH patients. [4] [5] [6] 9, 10 Most CDH survivors, however, have multiorgan problems and may require prolonged recovery periods. As a result, it is not surprising that early neurodevelopment may be delayed. The paucity of longitudinal data correlating early neurological findings with longer-term outcome limits our ability to make predictions of neurological outcomes from these short-term results. 7, 11 Longitudinal assessments are essential, particularly as it is increasingly recognized that some ND disabilities may be transient, whereas others may continue to evolve much later in life when more complex cognitive and executive skills are required.
In July 2004, we initiated an multidisciplinary effort called the Pulmonary Hypoplasia Program to provide standardized follow-up care of all infants seen at our institution with a diagnosis of CDH. 2, 6 As part of this prospective follow-up program, infants underwent comprehensive and coordinated standardized developmental evaluation at specified intervals. The primary objective of the current study was to report on the longitudinal ND and neuromotor outcome of CDH survivors during the first 3 years of life.
METHODS

Patient population
This was a retrospective review of prospectively collected data on ND and neurofunctional outcome in CDH survivors enrolled in our follow-up program between July 2004 and September 2010. The Institutional Review Board, Committee for Protection of Human Subjects of The Children's Hospital of Philadelphia approved this study, and all parents or legal guardians gave written informed consent for their children (IRB 2004-5-3779).
All CDH survivors born during the study period were eligible. Among this cohort, subjects who underwent ND assessment at least twice during the first 3 years of life were identified; this group forms the study population for this report. CDH children diagnosed with recognizable genetic or phenotypic syndrome, or subjects that underwent neurological evaluation only one time during the study period were excluded. Both premature infants and low birth weight neonates were enrolled, as were infants with additional concomitant congenital malformation (for example, lung lesions, giant omphalocele or non-cyanotic cardiac malformations).
Perinatal and postnatal management
Our protocol for the perinatal and postnatal management of children with prenatally diagnosed CDH has been previously described. 1, 6, 12 Briefly, the initial evaluation of all CDH patients referred to the Center for Fetal Diagnosis and Treatment at the Children's Hospital of Philadelphia includes detailed fetal ultrasonography and fetal ultrafast magnetic resonance imaging. Assessment includes confirmation of diagnosis, the type of CDH, liver position, lung-to-head ratio and the presence of other fetal anomalies. Fetal echocardiography and Doppler flow measurements were performed to assess cardiac anatomy and function. After evaluation, all patients underwent nondirective counseling for pregnancy management options. Fetal liver position is determined by ultrasound evaluation and confirmed by magnetic resonance imaging. Liver position is considered to be 'up' if any portion of the liver is in the chest above the normal level of the diaphragm and to be 'down' if the liver is completely within the abdomen. 12 The postnatal ventilatory management in the neonatal intensive care unit utilizes a lung-preservation strategy. 6, [12] [13] [14] The mode of ventilation is aimed at administering only enough pressure to maintain preductal oxygen saturations greater than 85%. High-frequency ventilation is reserved for neonates that continue to have hypercapnia refractory to conventional ventilation. If these therapies failed, neonates were then placed on venoarterial ECMO. The indications for ECMO included failure of conventional therapy as defined by inability to maintain preductal oxyhemoglobin saturations 485%, peak inspiratory pressure 428 cm H 2 O, mean airway pressure 415, pressor-resistant hypotension or inadequate oxygen delivery with development of metabolic acidosis. Relative contraindications to ECMO included gestational age o34 weeks and weight o2.0 kg. Repair of the CDH was performed in a delayed fashion once medical stability was achieved, the pulmonary vasculature became less reactive (absence of shunting) or weaning from ECMO was anticipated. The operating surgeon determined the need for patch placement based on the size of the diaphragmatic defect.
Data collection
Perinatal and postnatal factors that might independently affect ND and neuromotor outcomes, such as lung-to-head ratio, liver position, gestational age at delivery, birth weight, APGAR scores, ventilator days, ECMO need, type and age at repair, complications, O 2 requirement at DOL 30, length of stay and others, were obtained form hospital records.
ND examination
At the time of standardized ND assessment, growth measurements were obtained including weight, length and head circumference. As described elsewhere, ND outcome of CDH survivors was evaluated by either using the Bayley Scales of Infant Development II (BSID-II), if children were examined before 2006, or the BSID-III, if children were studied after 2006. 6 The BSID-II yields scores in two areas: psychomotor and mental development. The BISD-III yields scores on three domains: cognitive, language and neuromotor developmental outcome. The mean normative score for all tests is 100. The lowest assigned score was 50. Scores were grouped into average (X90), low-average (80 to 89), mildly delayed (70 to 79) and severely delayed (p69). Persistent ND impairment was defined as a score that remained p79 for the ND and functional domains at the most recent follow-up visit compared with the first assessment.
The neuromuscular examination (active tone, passive tone, reflexes, gross and fine motor abilities) was classified as normal if no abnormalities affecting motor skills were noted, suspect if a moderate degree of abnormality was noted and abnormal if functionally significant abnormalities of tone, reflexes or motor skills were present. Autism was diagnosed if the child met the symptom criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
Statistical analysis
Continuous data are expressed as means ± s.d. (median, range). Categoric data are expressed as proportions. Independent t-tests were used for comparison of continuous variables. Fisher's exact and w 2 tests were used for comparison of categoric variables as appropriate. Stepwise regression was used to assess associations between risk factors and neurocognitive outcomes. Po0.05 was considered statistically significant. All statistical tests were performed using JMP statistical software package (V 7.0, SAS, Cary, NC, USA).
RESULTS
Patient population
During the study period, overall 80 CDH survivors were enrolled in our follow-up program. Of those 47 (59%) returned at least twice for ND and neurofunctional assessment during the first 3 years of life. Baseline and operative characteristics were compared for the 47 returning patients and the 33 patients who did not return for serial assessment (Table 1) . Male patients were more likely to return (P ¼ 0.04), whereas there was no significant difference in other patient characteristics between both groups.
General neurological outcome of study population Each child's first and last available ND and neurological (for example, muscle tone and strength) assessment was used for analysis. The median age at first and last available evaluation was 8 (mean, 9.1 ± 3.1; range, 5 to 15) and 29 (mean, 28.6 ± 4.7; range, 23 to 36) months, respectively. For the first assessment, 28 (60%) children were below 1 year of age, 16 (34%) were 12 months and 3 (6%) were older than 12 months. At the time of re-evaluation, 16 (34%) children were between 23 and 24 months, 21 (45%) between 25 and 34 months and 10 (21%) were 36 months. The median difference between the two assessments was 20 (mean 19.6 ± 6; range, 9 to 30) months.
Cranial ultrasound studies during the neonatal period were available in 45 (96%) children. Of those, 36 (80%) had no signs of intraventricular hemorrhage (IVH), whereas 8 (18%) had grade 1 IVH and 1 (2%) had grade 2 IVH. PVL was found in 5 (11%) children. None of the CDH children developed seizures or had intraparenchymal hemorrhage. One (2%) child was diagnosed with autism. There was no case of cerebral palsy among the 47 children.
Neuromuscular hypotonicity and delayed motor coordination at the initial assessment was found in 33 (70%) and 22 (47%) children, respectively. Both neuromuscular hypotonicity (Po0.001) and delayed motor coordination (P ¼ 0.03) significantly improved. Hence at the time of re-evaluation, only 10 (21%) and 12 (26%) CDH children had neuromuscular hypotonicity and delayed motor coordination, respectively.
BSID-II and BSID-III developmental and functional outcome of study population Six (13%) children underwent their first and last assessment before 2006 and were evaluated using the BSID-II only. Overall scores for On the basis of individual testing scores, average, low-average, mildly delayed and severely delayed scores for neurocognitive and language skills were found in 31 (66%), 2 (4%), 9 (19%) and 5 (11%) children, respectively, at the initial assessment, and in 33 (70%), 3 (6%), 7 (15%) and 4 (9%) children, respectively, at the subsequent testing. Average, low-average, mildly delayed and severely delayed scores for overall motor skills at the first evaluation were found in 17 (36%), 9 (19%), 9 (19%) and 12 (26%) children, respectively, and in 32 (68%), 6 (13%), 6 (13%) and 3 (6%) children, respectively, at the last available evaluation. At initial evaluation, more children had motor impairments compared with language/cognitive skill impairment (Po0.001). No difference between these domains was found at the last assessment (P ¼ 0.41). During the follow-up, cognitive/language scores improved to low-average or average (n ¼ 8, 17%), remained low-average or average (n ¼ 27, 57%), remained delayed (n ¼ 4, 9%), deteriorated from low-average or average to delayed (n ¼ 7, 15%) and improved from severely delayed to mildly delayed (n ¼ 1, 2%). Motor scores improved to low-average or average (n ¼ 12, 26%), remained low-average or average (n ¼ 26, 55%), remained delayed (n ¼ 4, 8%), deteriorated (n ¼ 0, 0%) and improved from severely delayed to mildly delayed (n ¼ 5, 11%). On the basis of the overall improvements, 34 (72%) of the CDH infants scored within the low-average to average range for all three domains (that is, cognitive, language and neuromotor), whereas 8 (17%) were delayed in either ND or neurofunctional outcome and 5 (11%) had delays in cognitive, language and neuromotor functions, with 3 (6%) children being severely delayed in all three domains. The overall predictive values of the early ND and functional assessment on the subsequent outcomes are summarized in Table 2 .
Predictors of ND and neurofunctional outcome Stepwise regression analysis indicated that intrathoracic liver position (P ¼ 0.004), preterm delivery (P ¼ 0.03), supplemental O 2 requirement at DOL 30 (P ¼ 0.007), prolonged hospitalization (that is, age at discharge; P ¼ 0.03), PVL (P ¼ 0.004) and initial neuromuscular hypotonicity (P ¼ 0.01) were associated with persistent motor delays. Birth weight (P ¼ 0.06), gastroesophageal reflux disease (P ¼ 0.07), need for patch repair (P ¼ 0.09) and prolonged 
DISCUSSION
Although it has been previously reported that adverse ND and neuromotor outcome are common in CDH patients, little is known about the progress of those morbidities in the first 3 years of life.
In the present study, we evaluated the developmental outcome of a relatively large cohort of patients with CDH during the first 3 years of life. The use of standardized tests allowed the comparison of our study population with an age-related reference population. Our data confirm that considerable neurological morbidity exist in CDH survivors. 2, [4] [5] [6] [7] [8] [9] [10] 15, 16 Our research suggest, however, that developmental delays in CDH during infancy are more related to adverse psychomotor outcomes than neurocognitive delays. Assuming that CDH children, especially those with prolonged and complicated initial hospital course get little physical activity and have few opportunities to develop age-appropriate motor skills during the first year of life, the lower motor scores at the initial evaluation might not be unexpected. 17, 18 Further the relatively high incidence of neuromuscular hypotonicity (70%) and delayed motor coordination (47%) in CDH survivors at the initial assessment increases the risks of early neuromotor disabilities. Even though muscle weakness and coordinative delays were described as being mild-to-moderate in most children, it appears that it was significant enough to interfere with the acquisition, and quality of initial gross and fine motor milestones. Notably, an upward trend of the lower psychomotor scores, an improvement in coordinative skills and a decrease in neuromuscular hypotonicity during the follow-up period were observed, suggesting that early impairments of psychomotor function in CDH ameliorate over time or might be transient. Consequently, at the time of repeat evaluation the mean neurocognitive, language and psychomotor scores for the entire cohort tended to be within the average to low-average range for the general population. Despite the overall improvement in the performance, the number of children with mild-to-severe impairment in at least one ND domain was greater than expected for the general population.
Another finding of the current study is that once an infant was categorized as severely delayed in all three domains at the initial assessment, the likelihood of persistent significant ND and functional impairments during childhood remains high (sensitivity, 100%; specificity, 97%). Furthermore, a large majority of children who scored within the average to low-average range at the early neurological evaluation also scored in the normal range at the second assessment for cognitive, language and motor outcome (sensitivity, 61%; specificity, 93%). On the other hand, the relatively low sensitivity (77%) and low specificity (54%) for the cognitive and language domains suggest that early normal ND scores might be less predictive for longer-term outcome. Consequently, although CDH survivors with low performances during infancy should be placed under close ND surveillance, patients with mild deficits or even with average scores should also be monitored for indications of emerging developmental problems. Our research suggests that an early neurofunctional assessment could be a useful tool in alerting physicians to follow-up neurodevelopment to facilitate initiation of early intervention. These results will enable better test interpretation, parent counseling and some reassurance when testing CDH patients early in life.
Studies focusing on longitudinal neurological outcomes in the CDH population are scarce. 7, 16 To our best knowledge, there are only two reports evaluating the outcome in CDH children serially. Gischler et al. 16 prospectively measured the neurocognitive and neuromotor score of 12 CDH infants every 6 months for the first 2 years of life. NDl outcome was measured using the Dutch version of the BSID. Similar to our results, ND scores were better than motor scores. Mean mental development index scores at 6 and 24 months were in the average range, 97 (95% confidence interval (CI), 85 to 109) and 95 (95% CI, 76 to 115), respectively. Mean psychomotor development index slightly improved within the low-average range from 83 (95% CI, 71 to 95) at 6 months to 86 (95% CI, 66 to 106) at 24 months. Friedman et al. 7 followed 23 CDH children between 1 and 3 years of age. Of the 17 children noted to have neuromotor problems at 3 years of age, 13 already had variable degrees of neuromotor dysfunction at 1 year of age. Four (24%) had newly diagnosed neuromotor issues. Serial neurocognitive data were not reported in their study.
In the current study, we also evaluated both baseline and operative patient characteristics as modifiers or risk factors of persistent ND dysfunction during the first 3 years of life. We found that CDH children born with severe pulmonary hypoplasia (for example, intrathoracic liver position, supplemental O 2 at DOL 30 and prolonged hospitalization) were at higher risk for persistent neuromotor problems. Further, preterm delivery, the presence of PVL and initial neuromuscular hypotonicity were also associated with persistently lower psychomotor scores. These findings are in agreement with previous results, suggesting that neuromotor impairment in CDH comprises a complex interaction between preoperative, perioperative and postoperative events.
2,5,9 ECMO therapy is a known factor associated with adverse neurological outcome, but ECMO was not found to be associated with psychomotor dysfunction in our study. Interestingly, there is an increasing evidence that significant psychomotor problems also occur in CDH survivors and children with other congenial malformations that did not require ECMO during the neonatal period, suggesting that motor problems may not be specific to CDH, but a consequence of a congenital abnormality per se and might be related to factors such as the surgical procedure itself, potential effects of anesthetic medication and perioperative hypoxic/ischemic brain injury, or intrauterine factors such as altered fetal blood flow dynamics. 13, 19, 20 Additional studies directly comparing the neurological sequelae of various congenital anomalies are needed to further substantiate this assumption. Surprisingly, none of the potential predictors tested in the current study increased the susceptibility for persistent neurocognitive or language dysfunction. These findings further support our hypothesis that psychomotor dysfunction, at least during early childhood, may have a greater impact on developmental outcome in CDH than neurocognitive delays. It is Abbreviations: NPV, negative predictive value; PPV, positive predictive value.
Longitudinal neurodevelopmental outcome in CDH E Danzer et al well established that psychomotor dysfunction interferes with the acquisition of every day skills and neurocognitive and social emotional development. [21] [22] [23] Because psychomotor deficits have been associated with learning disorders and social difficulties, it is possible that subtle neurocognitive problems will become more evident with age. Continued longitudinal follow-up of our cohort will be an important area of ongoing research to not only to identify neurocognitive deficits in other domains, but also to find additional contributing factors for ND problems.
Although our results add to the understanding of ND and psychomotor problems in CDH patients, we recognize that there are several potential limitations. One challenge that is present in longitudinal studies is the changes in assessment tools from one age to another. This is unavoidable as the domains that we consider from toddler ages to school age do change. Another challenge occurs when an assessment tool undergoes restandardization and alters the domains of score. This occurred in our study with the use of combined results from the BSID-II and BSID-III in almost a quarter of our population. Data collection for this study extended over 6 years, during which time the BSID was revised. Comparisons were therefore made on the basis of the overall developmental categories rather than on the composite scores. 24 As is shown in Table 3 , the trends over time were similar for the children assessed with a single version of the assessment, and those who were assessed using the earlier and current version of the BSID. Another limitation of this study is the emphasis on biological predictors of outcome rather than environmental predictors. Demographic information such as maternal age, level of education and level of income were not routinely assessed for all patients at the time of this study and thus are not included in the analysis. The influence of environmental factors including age, education and other factors that have been found as predictors, such as the number of times a child is read to each week and parent conflict, will be a part of the next step of longitudinal follow-up of this cohort. Although the majority of CDH children enrolled in our follow-up program returned for serial assessment and no significant differences in baseline patient characteristics were found, we cannot exclude selection bias, which may limit the generalizability of our results. Data may not accurately capture the full aspects developmental limitations or reflect the outcome of the entire group, resulting in both type I and II errors in interpretation. Finally, although we found improvements in outcome, one should realize that neurocognitive, language and psychomotor outcomes are still relatively undifferentiated during early childhood and might not fully predict further recovery. Structural and continuous longitudinal assessment at predetermined time points as provided by our follow-up program will be essential to further predict outcomes.
In summary, our longitudinal follow-up evaluation showed that (1) the majority of children with CDH are functioning in the average range by early preschool age, (2) most children who had early delays showed improvement in their ND outcome, (3) those children showing delays in all the three domains were the least likely to show improvement, (4) CDH severity appears to be predictive of persistent psychomotor delays and (5) ECMO therapy was not associated with persistent psychomotor dysfunction. Early identification of children at risk allows earlier and possibly more targeted therapeutic interventions aimed at optimizing developmental and functional potential. Continuous assessment and follow-up as provided by an interdisciplinary team of medical, surgical and developmental specialists should become standard of care for all CDH children to identify and treat morbidities before additional disabilities evolve. Re-evaluation of preschool and school age outcomes are necessary to further define the natural history of adverse ND and neurofunctional outcome in children with CDH. Longitudinal neurodevelopmental outcome in CDH E Danzer et al
